Jean Christophe Barland
About Jean Christophe Barland
Jean Christophe Barland is the President of Japan, Korea, and Taiwan at Bristol-Myers Squibb, based in New Jersey, United States. He has extensive experience in leadership roles across various companies, including GSK and Nutricia Medical Nutrition.
Title
Jean Christophe Barland is the President, Japan, Korea, Taiwan at Bristol-Myers Squibb. He has been in this role since November 2017 and is based in New Jersey, United States.
Education and Expertise
Jean Christophe Barland has a rich educational background. He holds a Doctor of Veterinary Medicine from Lyon National Veterinary School (1985-1989) and studied Japanese Language at University of Lyon (iii) (1988-1990). He earned two Master of Business Administration degrees: one from Alliance Manchester Business School (1993-1995) and another from Duke University's Fuqua School of Business (1994). This diverse education equips him with in-depth knowledge in both medical and business disciplines.
Previous Roles at Bristol-Myers Squibb
Before his current role at Bristol-Myers Squibb, Jean Christophe Barland served as General Manager France and President Upsa Worldwide between 2012 and 2018. In this capacity, he led strategic initiatives and oversaw operations in these critical markets. This role was also based in New Jersey, United States.
Past Experience at Nutricia Medical Nutrition
Jean Christophe Barland served as the Managing Director for France and the North Africa Region at Nutricia Medical Nutrition, from 2010 to 2012. During this period, he managed the business operations and strategic development for these regions. His leadership helped steer the company through competitive landscapes.
Leadership Roles at GSK
At GSK, Jean Christophe Barland held several crucial roles. From 2008 to 2010, he was Vice President, Director of Operations for France, Primary Care, and French Overseas Territories. Prior to this, he was Vice President, Commercial Development for the Asia Pacific region (2006-2008), Business Unit Director, Neurology for the UK (2003-2005), Commercial Strategy Director for Neurodegenerative Diseases in Global Marketing Group (2001-2003), Associate Global Brand Director for Parkinson's Disease (1999-2001), and Associate Director of Marketing Research for CNS (1999). His tenure at GSK spanned diverse markets and roles, underlining his multifaceted expertise.